Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

FDA advisory committee recommends approval of Doxil sNDA

June 10, 1999

ODAC recommends approval of Ethyol for dry mouth

June 10, 1999

Protein kinase inhibitors from Glaxo for proliferative, metabolic and inflammatory disorders

June 9, 1999

New antitumor agents from Agouron acting as inhibitors of cyclin-dependent kinases

June 9, 1999

3-D structure of MMP-2 published

June 9, 1999

GlycoDesign seeks partners to advance the development of GlcNAc-TV enzyme inhibitors

June 9, 1999

Novel antitumor agents from Minophagen with an imidazo[1,5-a]pyrimidine structure

June 9, 1999

Pyrisulfoxins: new antibiotics isolated and tested for antileukemic activity

June 8, 1999

Bristol-Myers Squibb patents new paclitaxel-derived antitumor agents

June 8, 1999

Atrix completes phase I clinical trial for prostate cancer therapy

June 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...